Company reports cash of $29m as of Sept 30
Passage BIO reported a total of $29.3 million in cash and cash equivalents and $2.4 million in prepaid expenses. The company's net assets increased from $56.4 million to $62.7 million as of September 30, 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed